Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    NCT01252953
Show Display Options
Rank Status Study
1 Active, not recruiting REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
Condition: Atherosclerotic Cardiovascular Disease
Interventions: Drug: anacetrapib;   Drug: placebo anacetrapib
2 Not yet recruiting The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
Conditions: Atherosclerotic Cardiovascular Disease;   Vascular Disease
Interventions: Drug: Anacetrapib;   Drug: Statin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.